Michael J. Bradaric

609 citations
16 papers · 488 indexed · h-index 11

Michael J. Bradaric

16 papers receiving 481 citations

Peers

Michael J. Bradaric
Comparison fields: 5 of 72
  • Reproductive Medicine 176
  • Cancer Research 119
  • Oncology 124
  • Obstetrics and Gynecology 33
  • Animal Science and Zoology 39
Replace Marc Hirschfeld with:
Marc Hirschfeld Germany
Dingqing Feng China
Shu-Zhen Dai China
Chieh-Yang Cheng Taiwan
Keng Shen China
Ni Sima China
Yayun Gu China
Francesco Paolo Fiorentino Italy
Ling-juan Gao China
Michael J. Bradaric relative to Marc Hirschfeld Germany Marc Hirschfeld's profile →
Citations per field
00.5×4.9×
Marc Hirschfeld · 1×
Citations per year

Countries citing papers authored by Michael J. Bradaric

Since Specialization
Citations

This map shows the geographic impact of Michael J. Bradaric's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Bradaric with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Bradaric more than expected).

Fields of papers citing papers by Michael J. Bradaric

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Bradaric. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Bradaric. The network helps show where Michael J. Bradaric may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michael J. Bradaric, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael J. Bradaric Line = papers co-authored together Michael J. Bradaric links everyone, so they are left out of the graph.

All Works

16 of 16 papers shown
#Work
1 20213
2 20189
3 20161
4 2014107
5 201439
6 201311
7 201317
8 20115
9 201115
10 201028
11 201049
12 2009120
13 200924
14 200724
15 200732
16
Anti-tumor antibodies and ovarian cancer in Women and Hens
20064

About Michael J. Bradaric

Michael J. Bradaric is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Immunology, having authored 16 papers that have together received 488 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (8 papers), Immune Cell Function and Interaction (3 papers), Immunotherapy and Immune Responses (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Endometrial and Cervical Cancer Treatments (2 papers), Ultrasound and Hyperthermia Applications (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Reproductive Medicine (176 citations), Cancer Research (119 citations) and Oncology (124 citations). Michael J. Bradaric has collaborated with scholars based in United States and Israel. Frequent co-authors include Animesh Barua, Judith L. Luborsky, Seby Edassery, Pincas Bitterman, Jacques S. Abramowicz, Janice M. Bahr, Dale B. Hales, Lacey M. Litchfield, Iris L. Romero and Ernst Lengyel. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and American Journal of Obstetrics and Gynecology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026